In the former case, we found that the depletion of endogenous HMGCS1 or HMGCR leads to defects in neoangiogenesis and, to a lesser extent, to increased levels of basal apoptosis in cancer cells within the tumor mass. The gene discussed is HMGCR; the disease is cancer.